Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by inthnoon Nov 09, 2022 10:28am
137 Views
Post# 35085163

RE:Healthy movements..

RE:Healthy movements..I noticed you predicted up 20% on one of the other boards. Maybe that will pan out by days end, not really too concerned as predictions are tough in this market and especially with this company. Just curious on your thoughts on one thing, you stated solid gains will not come until a partnership or buyout is announced and usually I would agree with you, but do you not think that after this Fiday update and Kol on Monday that it would not warrant what one would call solid gains if the update is confirmatory of everything we are hoping. Really could the bigs just sit around and ignore a possible 90% ORR with at least lets say 7  and maybe more partial responses where there is no other trial in the world that has had similare results. But then again this is onc and history has been tough on us. Maybe just maybe someone will finally stand up and take notice. We shall see what the next week brings and hopefully confirmation and all good news.
<< Previous
Bullboard Posts
Next >>